Written by Klarity Editorial Team
Published: Jul 18, 2026

Last updated: July 18, 2026
If you have Anthem Blue Cross Blue Shield health insurance in New Hampshire and are managing ADHD, understanding your prescription drug benefits is essential. Anthem NH plans use Prime Therapeutics as their pharmacy benefit manager (PBM), which determines which ADHD medications are covered, at what cost, and under what prior authorization (PA) conditions. New Hampshire also has one of the broadest electronic prescribing for controlled substances (EPCS) laws in the country, applying to Schedule II through Schedule IV medications. Which directly affects how your provider must prescribe stimulant medications. This guide breaks down everything you need to know about Anthem ADHD coverage in New Hampshire for 2026.
Key facts for 2026:
- Insurer: Anthem Blue Cross Blue Shield of New Hampshire
- PBM: Prime Therapeutics
- Plan types: HMO, PPO, EPO, HDHP/HSA (individual, employer-sponsored, ACA marketplace)
- ADHD stimulants: Schedule II controlled substances. EPCS required under RSA 318-B:21-a
- Non-stimulants: Not scheduled. EPCS inapplicable; generally easier PA pathway
- NH parity law: RSA 417-E:1. Mental health coverage must be equivalent to medical/surgical coverage
- PA portal: Availity / anthem.com/provider
- NH Insurance Department: 1-800-852-3416
Ready to connect with a licensed ADHD provider who accepts Anthem in New Hampshire? Explore ADHD treatment options at Klarity Health and see if you may qualify for care.
Anthem Blue Cross Blue Shield is one of the largest commercial health insurers operating in New Hampshire, offering plans across the individual, small group, large group, and ACA marketplace markets. Anthem NH uses Prime Therapeutics as its pharmacy benefit manager. The same PBM used by many Anthem Blue Cross Blue Shield plans across the country. Prime Therapeutics manages the drug formulary, sets tier placements, and administers prior authorization decisions for prescription medications, including ADHD treatments.
Anthem NH plan types include HMOs that require a primary care physician referral for specialist care, PPOs that offer in-network and out-of-network flexibility, EPOs that restrict coverage to network providers, and HDHPs paired with HSAs. Your specific formulary tier placements and cost-sharing obligations depend on which Anthem NH plan you hold.
Prime Therapeutics organizes covered drugs into tiers. Lower tiers generally have lower cost-sharing; higher tiers may require step therapy or prior authorization. The table below reflects typical Prime Therapeutics tier placements for ADHD medications in 2026. Always verify your specific plan’s formulary at anthem.com or by calling Prime Therapeutics directly, as tier placements may vary by plan.
| Medication | Type | Typical Tier | PA Required | NH EPCS Required |
|---|---|---|---|---|
| Amphetamine salts generic (Adderall generic) | Stimulant (Schedule II) | Tier 1. 2 | Quantity limits; PA for higher doses | Yes. RSA 318-B:21-a |
| Adderall XR (brand) / mixed amphetamine salts XR generic | Stimulant (Schedule II) | Tier 2. 3 | Often step therapy from generic IR first | Yes. RSA 318-B:21-a |
| Lisdexamfetamine (Vyvanse generic / Vyvanse brand) | Stimulant (Schedule II) | Tier 2. 3 | PA likely; generic preferred | Yes. RSA 318-B:21-a |
| Methylphenidate generic (Ritalin/Concerta generic) | Stimulant (Schedule II) | Tier 1. 2 | Quantity limits; PA for higher doses | Yes. RSA 318-B:21-a |
| Concerta brand / Ritalin brand | Stimulant (Schedule II) | Tier 3. 4 | Step therapy from generic first | Yes. RSA 318-B:21-a |
| Dextroamphetamine (Dexedrine generic) | Stimulant (Schedule II) | Tier 1. 2 | Quantity limits | Yes. RSA 318-B:21-a |
| Focalin XR / dexmethylphenidate generic | Stimulant (Schedule II) | Tier 2. 3 | PA sometimes required | Yes. RSA 318-B:21-a |
| Atomoxetine (Strattera generic) | Non-stimulant (not scheduled) | Tier 1. 2 | Usually no PA for generic | No. Not a controlled substance |
| Viloxazine (Qelbree) | Non-stimulant (not scheduled) | Tier 3. 4 | PA likely | No. Not a controlled substance |
| Guanfacine ER (Intuniv generic) | Non-stimulant (not scheduled) | Tier 1. 2 | Usually no PA for generic | No. Not a controlled substance |
| Clonidine ER (Kapvay generic) | Non-stimulant (not scheduled) | Tier 1. 2 | Usually no PA for generic | No. Not a controlled substance |
| Bupropion (Wellbutrin. Off-label ADHD) | Non-stimulant (not scheduled) | Tier 1 | No PA for generic | No. Not a controlled substance |
Note: Generic lisdexamfetamine (formerly Vyvanse) became available in 2023. Your Anthem plan may have updated its tier placement. Verify current formulary status with Prime Therapeutics or at anthem.com before filling.
Prior authorization is a formal approval process your provider must complete before your plan will cover certain medications. For Anthem NH plans managed by Prime Therapeutics, PA is commonly required for:
Your provider typically submits a PA request through Availity or directly through anthem.com/provider. PA requests are generally reviewed within 1. 3 business days for standard requests and within 24. 72 hours for urgent/expedited requests. If prior authorization is denied, you have the right to an appeal. First at the plan level, then through an external review organization, and ultimately through the New Hampshire Insurance Department.
New Hampshire’s electronic prescribing for controlled substances law. Codified at RSA 318-B:21-a. Is notably broader than the federal standard and the laws of many other states. While some states limit EPCS requirements to Schedule II controlled substances only (the same category as federal DEA e-prescribing guidance), New Hampshire’s law covers Schedule II through Schedule IV controlled substances.
For ADHD prescriptions specifically, this means:
| Medication Category | DEA Schedule | NH EPCS Required? | Notes |
|---|---|---|---|
| Amphetamine-based stimulants (Adderall, Vyvanse, Dexedrine) | Schedule II | Yes | RSA 318-B:21-a; no paper prescriptions |
| Methylphenidate-based stimulants (Ritalin, Concerta, Focalin) | Schedule II | Yes | RSA 318-B:21-a; no paper prescriptions |
| Atomoxetine (Strattera) | Not scheduled | No | EPCS inapplicable. Not a controlled substance |
| Viloxazine (Qelbree) | Not scheduled | No | EPCS inapplicable. Not a controlled substance |
| Guanfacine ER / Clonidine ER | Not scheduled | No | EPCS inapplicable. Not a controlled substance |
In practice, this means that if your Anthem NH provider is prescribing a Schedule II stimulant. Which covers all amphetamine and methylphenidate-based ADHD medications. The prescription must be sent electronically to your pharmacy. Paper prescriptions for these medications are generally not permitted under NH law (limited exceptions apply for system outages or other technical failures). This requirement is already standard practice for most prescribers using electronic health record systems, but it is worth confirming your provider’s EPCS capability if you are starting with a new prescriber in New Hampshire.
Non-stimulant ADHD medications like atomoxetine, viloxazine, guanfacine, and clonidine are not controlled substances and are entirely outside the EPCS framework. These can be prescribed electronically or on paper with no statutory restriction.
New Hampshire’s mental health parity law, codified at RSA 417-E:1 et seq., requires that health insurance plans covering mental health and substance use disorder (MH/SUD) benefits provide those benefits at a level no more restrictive than the plan’s medical or surgical benefits. This parity requirement applies to:
ADHD is classified under mental health (ICD-10: F90.x), so RSA 417-E:1 applies to your ADHD coverage. If you believe Anthem is applying more restrictive criteria to your ADHD prescription than it would apply to a comparable medical or surgical drug, you may file a parity complaint with the New Hampshire Insurance Department at 1-800-852-3416.
Note that RSA 417-E:1 applies to fully insured commercial plans. Self-funded employer plans governed by ERISA are subject to the federal Mental Health Parity and Addiction Equity Act (MHPAEA) rather than the state parity statute, though the protections are substantively similar.
Before booking a provider appointment, take these steps to confirm your ADHD coverage:
Klarity Health is a telehealth platform connecting patients with licensed ADHD providers across New Hampshire and nationwide. With 2,000+ licensed providers in the network, Klarity makes it easier to access ADHD evaluation and ongoing medication management from the comfort of your home.
Klarity providers are familiar with New Hampshire’s EPCS requirements and can transmit Schedule II stimulant prescriptions electronically to your preferred pharmacy. They can also help navigate prior authorization requests when required by your Anthem plan.
Check if you may qualify for ADHD treatment through Klarity Health. Coverage may vary by plan. Always verify your benefits before booking.
Anthem NH plans administered through Prime Therapeutics typically cover a range of ADHD medications, including generic stimulants at Tier 1. 2 and brand-name medications at higher tiers with prior authorization. Coverage details, including which specific drugs are covered and at what cost-sharing level, may vary by plan. Always verify your formulary at anthem.com or by calling Prime Therapeutics.
PA requirements depend on the specific medication and your plan. Generic stimulants at standard doses often have fewer PA hurdles, while brand-name medications, higher doses, or non-preferred non-stimulants are more likely to require PA. Your provider can submit a PA request through Availity or anthem.com/provider.
Generally no. Under RSA 318-B:21-a, Schedule II controlled substances like Adderall and Ritalin must be prescribed electronically in New Hampshire. Limited exceptions exist (e.g., technical system failures), but electronic prescribing is the standard for all compliant NH prescribers.
If you have a fully insured Anthem NH plan, RSA 417-E:1 applies. Anthem may not impose more restrictive PA or coverage criteria on your ADHD medication than it would on a comparable medical or surgical drug. Self-funded ERISA plans follow federal MHPAEA rather than state parity law.
Generic lisdexamfetamine is available and is typically covered at a lower tier than the Vyvanse brand. Your plan may require a trial of generic lisdexamfetamine before approving brand Vyvanse. Verify current tier placement with Prime Therapeutics.
You have the right to appeal. Start with an internal appeal to Anthem, then request an external review. If you believe a parity violation contributed to the denial, you may also file a complaint with the NH Insurance Department at 1-800-852-3416.
Disclaimer: This content is for informational purposes only and does not constitute medical or legal advice. Insurance coverage for ADHD treatment may vary significantly by plan, employer, and individual circumstances. Always verify your specific benefits with Anthem and Prime Therapeutics before seeking care. Klarity Health cannot guarantee coverage outcomes.
Find the right provider for your needs — select your state to find expert care near you.